Financial Architects (New Jersey)’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Financial Architects (New Jersey)’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	–	–	1587
2018 Q4	$0	Hold	200	–	–	﹤0.01%	1563
2018 Q3	$1K	Hold	200	–	–	﹤0.01%	1398
2018 Q2	$1K	Hold	200	–	–	﹤0.01%	1306
2018 Q1	$1K	Hold	200	–	–	﹤0.01%	1372
2017 Q4	$2K	Hold	200	–	–	﹤0.01%	1430
2017 Q3	$2K	Buy	200 +90	+82%	+$1.28K	﹤0.01%	1432
2017 Q2	$2K	Hold	110	–	–	﹤0.01%	1459
2017 Q1	$3K	Hold	110	–	–	﹤0.01%	1414
2016 Q4	$3K	Buy	+110	New	+$3.07K	﹤0.01%	1265

Financial Architects (New Jersey)'s IPCI Position: Q1 2019 in Review

Financial Architects (New Jersey) sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 200 shares.

Financial Architects (New Jersey) first reported a position in IPCI in Q4 2016 and held it in 9 quarters. The position peaked at $3K in Q1 2017. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

Financial Architects (New Jersey) reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 200 Intellipharmaceuticals International Inc. shares in Q1 2019.
Financial Architects (New Jersey) first reported a position in Intellipharmaceuticals International Inc. in Q4 2016 and held it in 9 quarters.
Financial Architects (New Jersey)'s Intellipharmaceuticals International Inc. position peaked at $3K in Q1 2017.
0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2019, filed 3 May 2019.